4A41.20

ICD-11 MMS 2026-01

Inflammatory inclusion body myositis

Description

Inclusion body myositis (IBM) is the most common idiopathic inflammatory myopathy after age 50. It typically presents with chronic insidious proximal leg and/or distal arm asymmetric muscle weakness leading to recurrent falls and loss of dexterity. Creatine kinase is up to 15 times elevated in IBM and needle electromyography mostly shows a chronic irritative myopathy. Muscle histopathology demonstrates endomysial inflammatory exudates surrounding and invading non-necrotic muscle fibres often times accompanied by rimmed vacuoles and protein deposits. Despite inflammatory muscle pathology, it is likely that IBM has a prominent degenerative component as supported by refractoriness to immunosuppressive therapy.

Index terms

  • Inflammatory inclusion body myositis
  • Inflammatory IBM - [inflammatory inclusion body myositis]
  • Sporadic inclusion body myositis
Show allHide
  • Hereditary inclusion body myositis
  • Familial inclusion body myositis
  • UPD-GlcNac epimerase/kinase deficiency

Excludes

  • http://id.who.int/icd/entity/1425591047 – Myasthenia gravis or certain specified neuromuscular junction disorders

Exclusions from above levels

  • 02 – Neoplasms
  • 18 – Complications of pregnancy, childbirth and the puerperium
  • 20 – Developmental anomalies

Sibling codes

  • 4A41.21 – Noninflammatory inclusion body myopathy
  • 4A41.2Z – Inclusion body myopathy, unspecified

Foundation entity

Inflammatory inclusion body myositis – http://id.who.int/icd/entity/797555186

Part of: 4A41.2: Inclusion body myopathy › 4A41: Idiopathic inflammatory myopathy › 04: Diseases of the immune system